Showing 41 - 60 of 82 results
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
Health researchers at ANSTO use world-class nuclear and isotopic techniques to undertake research and development activities to address some of the most challenging health problems.
A large team of ANSTO scientists in collaboration with University of Wollongong researchers has developed a new hybrid technique that enhances the effectiveness of a cutting-edge form of radiation therapy for advanced cancer.
Tool developed for producing F-18 radiopharmaceuticals for PET imaging.
Study explored how key proteins manage dietary cholesterol absorption and elucidated crucial transport mechanisms that contribute to cholesterol balance in the body.
Our goal is to create an inclusive, respectful symposium environment that invites participation from people of all races, ethnicities, genders, ages, abilities, religions, and sexual orientations.
Useful in some mineral processes but a major problem in others, jarosite may be the key to unlocking the geological history and environmental context of water on Mars.
PHD student Dr Leonie van ‘t Hag has been awarded the prestigious 2017 ANSTO, Australian Synchrotron Stephen Wilkins Medal for her PhD thesis.
In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.
The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.
ANSTO works in partnerships and collaborative ventures with national and international organisations. Partner with ANSTO.
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
ANSTO physicist will gain further experience in particle therapy technologies.
Consultant appointed to consider a variety of financial, manufacture and import options.
